Harrow to Participate in Three Investor Conferences in September
Rhea-AI Summary
Harrow (Nasdaq: HROW) announced that management will participate in three investor conferences in New York in September 2026: the Cantor Global Healthcare Conference on September 9 at 1:35 p.m. ET, Lake Street Capital Markets Best Ideas Growth Conference on September 10, and H.C. Wainwright Global Investment Conference on September 15 at 11:00 a.m. ET. Fireside chats at Cantor and H.C. Wainwright will be webcast live and archived for about 90 days on Harrow’s website Events page.
Positive
- None.
Negative
- None.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Aug 20 | IHEEZO clinical data | Positive | +1.1% | Patient-reported discomfort was lower with IHEEZO in a randomized eye study. |
| Aug 10 | 2Q26 earnings report | Negative | -3.0% | Revenue grew, but net loss and Adjusted EBITDA deterioration outweighed operating growth. |
| Aug 06 | TYRVAYA acquisition | Positive | +1.3% | Harrow agreed to acquire global TYRVAYA rights for upfront cash and milestones. |
| Jul 27 | 2Q26 earnings date | Neutral | -2.6% | Harrow scheduled its second-quarter results release and following investor conference call. |
| Jul 20 | BYOOVIZ clinical data | Positive | -4.7% | Interim Phase 4 data reported statistically significant visual and thickness changes. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Reactions were mixed: the acquisition and latest IHEEZO data were followed by gains, while earnings and earlier BYOOVIZ data were followed by declines.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NASHVILLE, Tenn., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that management will participate in the following three investor conferences in September in New York, NY:
2026 Cantor Global Healthcare Conference
- Format: Fireside chat + 1x1 investor meetings
- Date/Time: Wednesday, September 9, 2026, at 1:35 p.m. ET
Lake Street Capital Markets 10th Annual Best Ideas Growth Conference
- Format: 1x1 investor meetings
- Date/Time: Thursday, September 10, 2026
H.C. Wainwright 28th Annual Global Investment Conference
- Format: Fireside chat + 1x1 investor meetings
- Date/Time: Tuesday, September 15, 2026, at 11:00 a.m. ET
The fireside chats at Cantor and H.C. Wainwright will be webcast live and can be accessed on the Events page of the Company’s website. A replay of each webcast will be available for approximately 90 days following the applicable event. Investors interested in meeting with management during any of these conferences should contact their representative at the sponsoring firm to request a meeting.
About Harrow
Harrow, Inc. (Nasdaq: HROW) is a leading provider of ophthalmic disease management solutions in North America, offering a comprehensive portfolio of products that address conditions affecting both the front and back of the eye, such as dry eye disease, wet (or neovascular) age-related macular degeneration, cataracts, refractive errors, glaucoma and a range of other ocular surface conditions and diseases of the retina. Harrow was founded with a commitment to deliver safe, effective, accessible, and affordable medications that enhance patient compliance and improve clinical outcomes. For more information about Harrow, please visit harrow.com and connect with us on LinkedIn.
Contacts:
Mike Biega
Vice President of Investor Relations and Communications
mbiega@harrowinc.com
617-913-8890
